论文部分内容阅读
研究证明,经导管动脉栓塞(TAE)联合经皮穿刺乙醇注射(PEI)治疗孤立性大肝细胞癌(HCC)与单用TAE相比,能明显提高3年存活率,明显降低局部复发率,但该联合疗法的长期存活结果尚一直无人探讨。现首次报告以该法治疗孤立性或多发性大HCC的10年经验总结。
Studies have shown that the treatment of isolated hepatocellular carcinoma (HCC) by transcatheter arterial embolization (TAE) combined with percutaneous ethanol injection (PEI) can significantly improve the 3-year survival rate and significantly reduce the local recurrence rate compared with TAE alone. However, the long-term survival of the combination therapy has not been discussed. The 10-year experience summary of the treatment of isolated or large HCC treated with this method is reported for the first time.